Diabetes 59 , 30993107 (2010)
Some patients report a milder initial experience with oral options, though this varies individually
Are GLP-1 Medications Right for Everyone
This analysis is based on Planet Fitness Q4 2025 earnings releases and call transcripts, Life Time Group Holdings 8-K filings and earnings call transcripts, the Ro press release announcing the Serena Williams partnership, Athletech News, CNBC, Bloomberg, NBC News, the New England Journal of Medicine, Morgan Stanley Research notes on GLP-1 consumer impact, and reporting from Quartz, Fast Company, and the Boring Business Nerd newsletter
All data were analyzed using Prism GraphPad 9 or Stata/SE 14.2
When weighed against the financial and health costs of weight regain, including renewed medication courses, worsening metabolic disease, and associated healthcare utilization, the maintenance approach frequently wins on pure economics